tiprankstipranks
Trending News
More News >
TNF Pharmaceuticals (TNFA)
NASDAQ:TNFA
US Market

TNF Pharmaceuticals (TNFA) Financial Statements

Compare
565 Followers

TNF Pharmaceuticals Financial Overview

TNF Pharmaceuticals's market cap is currently $1.94M. The company's EPS TTM is $-11.725; its P/E ratio is ―; TNF Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -29.45K
Operating Income$ -10.17M$ -17.12M$ -15.28M$ -28.20M$ -12.29M
EBITDA$ -23.36M$ -4.00M$ 0.00$ -29.28M$ -12.12M
Net Income$ -23.36M$ -4.00M$ -15.20M$ -29.89M$ -17.58M
Balance Sheet
Cash & Short-Term Investments$ 8.52M$ 4.92M$ 4.84M$ 11.56M$ 35.34M
Total Assets$ 21.42M$ 17.86M$ 17.54M$ 24.81M$ 36.84M
Total Debt$ 10.58K$ 48.87K$ 141.72K$ 149.15K$ 4.13M
Net Debt$ -162.57K$ -2.63M$ -607.37K$ -406.82K$ -14.49M
Total Liabilities$ 6.70M$ 5.09M$ 2.84M$ 1.17M$ 2.26M
Stockholders' Equity$ 14.72M$ 12.77M$ 14.70M$ 23.65M$ 34.58M
Cash Flow
Free Cash Flow$ -8.98M$ -12.98M$ -12.27M$ -19.52M$ -11.92M
Operating Cash Flow$ -8.98M$ -12.98M$ -12.27M$ -19.52M$ -11.92M
Investing Cash Flow$ -6.10M$ 1.85M$ 6.91M$ 19.85M$ -8.76M
Financing Cash Flow$ 12.57M$ 13.07M$ 5.55M$ 73.53K$ 38.67M
Currency in USD

TNF Pharmaceuticals Earnings and Revenue History

TNF Pharmaceuticals Debt to Assets

TNF Pharmaceuticals Cash Flow

TNF Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis